AlzeCure Pharma AB Financial Overview
AlzeCure Pharma AB's market cap is currently kr247.07M. The company's EPS TTM is kr-0.091; its P/E ratio is -5.31; AlzeCure Pharma AB is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
